No Data
YSB has initiated a share buyback of up to 0.1 billion yuan, driven by multiple bullish factors for valuation recovery.
Recently, YSB (9885.HK) has continuously released Bullish Signals. An announcement on May 7 showed that the company, based on the 2024 share buyback authorization, repurchased a total of 300,000 shares for a total cost of approximately 2.104 million Hong Kong dollars, averaging 7.0147 Hong Kong dollars per share, and the repurchased shares will be canceled. The company plans to use up to 0.1 billion Hong Kong dollars in the open market to repurchase shares before October 31, 2025. The buyback plan is being efficiently advanced, demonstrating the company's positive expectations for its performance and the future market. The management is also simultaneously increasing its Shareholding to boost confidence, with Executive Director Chen Fei continuously increasing his holdings by 0.5 million shares in April (approximately 3.
Express News | YSB Inc - Intends to Utilise up to HK$100 Mln for Repurchase of Shares on Open Market
Health Check: How Prudently Does YSB (HKG:9885) Use Debt?
YSB: 2024 ANNUAL REPORT
YSB (09885.HK) awarded 0.98 million shares as bonus shares.
On April 3, 2023, YSB (09885.HK) announced that on April 3, 2025, the company will grant 0.98 million award shares to the award recipients under the 2023 Share Incentive Plan, involving 0.98 million new shares, accounting for approximately 0.14% of the total issued shares as of the announcement date.
The new forces in medicine under the surge of AI: Decoding the intelligent secrets behind YSB (9885.HK) performance turnaround.
Nowadays, AI unquestionably stands at the forefront, becoming the absolute main line chased by capital. The "AI + Medical" integration is seen by the market as the most explosive strategic high ground due to its potential to reconstruct traditional diagnostic and treatment models. As the AI wave sweeps through the healthcare industry, YSB (9885.HK), China’s largest outpatient pharmaceutical digital comprehensive service platform, recently presented its performance report for 2024, providing vivid proof of this technological revolution. The Earnings Reports show that the company's annual revenue grew by 5.5% year-on-year to 17.904 billion yuan, with net income exceeding 30.01 million yuan, achieving a full positive turnaround for the first time, with adjusted net income reaching.
